Patent details

EP3419625 Title: METHODS FOR USING FXR AGONISTS

Basic Information

Publication number:
EP3419625
PCT Application Number:
IB2017050963
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177091899
PCT Publication Number:
WO2017145041
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR USING FXR AGONISTS
French Title of Invention:
MÉTHODES D'UTILISATION D'AGONISTES DE FXR
German Title of Invention:
VERFAHREN ZUR VERWENDUNG VON FXR-AGONISTEN
SPC Number:

Dates

Filing date:
20/02/2017
Grant date:
07/04/2021
EP Publication Date:
02/01/2019
PCT Publication Date:
31/08/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2021
EP B1 Publication Date:
07/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/02/2022
Expiration date:
20/02/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
CHEN, Jin
Address:
United States (US)

2

Name:
LAFFITTE, Bryan
Address:
United States (US)

3

Name:
BADMAN, Michael
Address:
United States (US)

4

Name:
LINDGREN, Sam
Address:
Switzerland (CH)

Priority

1

Priority Number:
201662298121 P
Priority Date:
22/02/2016
Priority Country:
United States (US)

2

Priority Number:
201662420661 P
Priority Date:
12/12/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/46; A61K 31/4748; A61K 31/497; A61K 31/506; A61P 1/00; A61P 1/16;

Publication

European Patent Bulletin

Issue number:
202114
Publication date:
07/04/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages